Home Business AstraZeneca Takes Action, Caps Inhaler Price at $35 Amidst Scrutiny Over Drug Costs

AstraZeneca Takes Action, Caps Inhaler Price at $35 Amidst Scrutiny Over Drug Costs

by Sonia Park
0 comment
AstraZeneca Takes Action, Caps Inhaler Price at $35 Amidst Scrutiny Over Drug Costs

AstraZeneca, a leading pharmaceutical company, has announced its decision to cap the cost of its inhalers at $35, a move aimed at addressing concerns over exorbitant drug prices in the United States. The decision, which takes effect on June 1st, comes. . .

You have exceeded the number of free content views. To continue viewing exclusive JudgeNap content,  you'll need a subscription. Please choose your subscription plan here.

Already a member?  Login here.

You may also like

Our Company

Judge Andrew P. Napolitano – Judging Freedom – JudgeNap.com

Newsletter

Subscribe to the Judging Freedom Newsletter and stay updated!

Laest News

@2023 – All Right Reserved. Designed and Developed by:

 Christopher Leonard – OMG Media Partners, LLC.

-
00:00
00:00
Update Required Flash plugin
-
00:00
00:00